Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.130
-0.190 (-5.72%)
At close: Oct 14, 2026, 4:00 PM EDT
3.129
-0.001 (-0.02%)
After-hours: Oct 14, 2026, 7:57 PM EDT

Prime Medicine Revenue

Prime Medicine had revenue of $1.15M in the quarter ending June 30, 2026, with 3.50% growth. This brings the company's revenue in the last twelve months to $4.07M, down -17.90% year-over-year. In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth. That makes Prime Medicine the 40,579th largest company in the world by revenue and 5,425th in the United States.

Revenue (ttm)
$4.07M
Revenue Growth
-17.90%
P/S Ratio
136.72
Revenue / Employee
$27,897
Employees
146
Market Cap
556.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.63M1.65M55.28%
Dec 31, 20242.98M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Pharming Group366.48M
MiMedx Group355.17M
Zevra Therapeutics136.07M
Wave Life Sciences65.37M
OmniAb38.46M
Crescent Biopharma11.88M
Avalo Therapeutics59.00K
Revenue Rankings